Flow Cytometer Performance Characterization, Standardization and Calibration against CD4 on T Lymphocytes Enables Quantification of Biomarker Expressions for Immunological Applications
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48151#.VEXyOVfHRK0
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48151#.VEXyOVfHRK0
Author(s)
Center for Biologics Evaluation and Research, US Food and Drug Administration (FDA), Bethesda, Maryland, USA.
Center for Biologics Evaluation and Research, US Food and Drug Administration (FDA), Bethesda, Maryland, USA.
Center for Devices and Radiological Health, FDA, Silver Spring, Maryland, USA.
National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, USA.
Center for Biologics Evaluation and Research, US Food and Drug Administration (FDA), Bethesda, Maryland, USA.
Center for Devices and Radiological Health, FDA, Silver Spring, Maryland, USA.
National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, USA.
There is an urgent need for developing a procedure
for biomarker standardization and relative quantificationin clinical
laboratories. Measuring the expression levels of cell antigens is
critical for the diagnosis of many diseases, e.g. leukemia, lymphoma and
immunodeficiency diseases. One of the most significant challenges in
flow cytometry is obtaining inter-laboratory and intra-laboratory
consistent and reproducible results across multiple cytometer platforms
and locations longitudinally over time. To obtain measurement
consistency, the target flow cytometer voltages should be optimized to
segregate the negative population from the electronic noise, and to keep
the brightest positive population within the dynamic range of each
detector. Then target values should be determined and transferred to
selected cytometers. In this study, we optimized a procedure for
instrument standardization across three different flow cytometer
platforms from the same vendor and in two different locations. The
biomarker quantification was implemented on standardized instruments
using CD4 expression on T lymphocytes with a known amount of antibody
bound per cell as a quantification standard. Our results on blood cell
subset typing and CD19 quantification demonstrated that consistent and
reliable results could be accomplished between instruments using the
developed procedure. Quantitating the expression levels of certain cell
biomarkers relative to a known reference marker before, during, and
after therapy would provide important information for monitoring
antibody-based therapy and could be potentially used to adjust dosing.
Presently, we are implementing this protocol to quantify critical
disease biomarkers, and making necessary modifications to the procedure
to include instruments from different instrument manufacturers.
KEYWORDS
Cite this paper
Degheidy, H. , Bauer, S. , Marti, G. and Wang, L.
(2014) Flow Cytometer Performance Characterization, Standardization and
Calibration against CD4 on T Lymphocytes Enables Quantification of
Biomarker Expressions for Immunological Applications. Journal of Biomedical Science and Engineering, 7, 756-768. doi: 10.4236/jbise.2014.79074.
[1] |
Van de Loosdrecht, A.A., Alhan,
C., Bene, M.C., Della Porta, M.G., Drager, A.M., Feuillard, J., et al.
(2009) Standardization of Flow Cytometry in Myelodysplastic Syndromes:
Report from the First European Leukemia Net Working Conference on Flow
Cytometry Inmyelodysplastic Syndromes. Haematologica, 94, 1124-1134. http://dx.doi.org/10.3324/haematol.2009.005801 |
[2] |
Bjorklund, E., Matinlauri, I.,
Tierens, A., Axelsson, S., Forestier, E., Jacobsson, S. et al. (2009)
Quality Control of Flow Cytometry Data Analysis for Evaluation of
Minimal Residual Disease in Bone Marrow from Acute Leukemia Patients
during Treatment. Journal of Pediatric Hematology/Oncology, 31, 406-415.
http://dx.doi.org/10.1097/MPH.0b013e3181a1c0e8 |
[3] |
Dworzak, M.N., Gaipa, G., Ratei,
R., Veltroni, M., Schumich, A., Maglia, O., et al. (2008)
Standardization of Flow Cytometric Minimal Residual Disease Evaluation
in Acute Lymphoblastic Leukemia: Multicentric Assessment Is Feasible.
Cytometry Part B: Clinical Cytometry, 74, 331-340. http://dx.doi.org/10.1002/cyto.b.20430 |
[4] |
Irving, J., Jesson, J., Virgo,
P., Case, M., Minto, L., Eyre, L., et al. (2009) Establishment and
Validation of a Standard Protocol for the Detection of Minimal Residual
Disease in B Lineage Childhood Acute Lymphoblastic Leukemia by Flow
Cytometry in a Multicenter Setting. Haematologica, 94, 870-874. http://dx.doi.org/10.3324/haematol.2008.000414 |
[5] | Letestu, R., Rawstron, A., Ghia, P., Villamor, N., Leuven, N.B., Boettcher, S., Buhl, A.M., Duerig, J., Ibbotson, R., Kroeber, A., Langerak, A., Le Garff-Tavernier, M. and Mockridge, I. (2006) Evaluation of ZAP-70 Expression by Flow Cytometry in Chronic Lymphocytic Leukemia: AMulticentric International Harmonization Process. Cytometry Part B (Clinical Cytometry), 70B, 309-314. |
[6] | Kraan, J., Gratama, J.W., Keeney, M., D’Hautcourt, J.L. (2003) Setting up and Calibration of a Flow Cytometer for Multicolor Immunophenotyping. Journal of Biological Regulators Homeostatic Agents, 17, 223-233. |
[7] |
Shankey, T.V., Forman, M.,
Scibelli, P., Cobb, J., Smith, C.M., Mills, R., et al. (2006) An
Optimized Whole Blood Method for Flow Cytometric Measurement of ZAP-70
Protein Expression in Chronic Lymphocytic Leukemia. Cytometry Part B:
Clinical Cytometry, 70, 259-269. http://dx.doi.org/10.1002/cyto.b.20135 |
[8] |
Kalina, T., Flores-Montero, J.,
van der Velden, V.H.J., Martin-Ayuso, M., Bottcher, S., Ritgen, M.,
Almeida, J., Lhermitte, L., Asnafi, V., Mendonca, A., de Tute, R.,
Cullen, M., Sedek, L., Vidriales, M.B., Perez, J.J., teMarvelde, J.G.,
Mejstrikova, E., Hrusak, O., Szczepanski, T., van Dongen, J.J.M. and
Orfao, A. (2012) On Behalf of the EuroFlow Consortium. EuroFlow
Standardization of Flow Cytometer Instrument Settings and
Immunophenotyping Protocols. Leukemia, 26, 1986-2010. http://dx.doi.org/10.1038/leu.2012.122 |
[9] |
Hultin, L.E., Matud, J.L. and
Giorgi, J.V. (1998) Quantitation of CD38 Activation Antigen Expression
on CD8+ T cells in HIV-1 Infection Using CD4 Expression on CD4+ T
Lymphocytes as a Biological Calibrator. Cytometry, 33, 123-132. http://dx.doi.org/10.1002/(SICI)1097-0320(19981001)33:2<123::AID-CYTO6>3.0.CO;2-K |
[10] |
Wang, L., Gaigalas, A.K., Marti,
G.E., Abbasi, F. and Hoffman, R.A. (2008) Toward Quantitative
Fluorescence Measurements with Multicolor Flow Cytometry. Cytometry Part
A, 73A, 279-288. http://dx.doi.org/10.1002/cyto.a.20507 |
[11] | Wang, L., Gaigalas, A.K. and Yan, M. (2011) Quantitative Fluorescence Measurements with Multicolor Flow Cytometry. Flow Cytometry Protocols, 3rd Edition, Humana Press/Springer, New York, 53-65. |
[12] |
Poncelet, P., Poinas, G.,
Corbeau, P., Devaux, C., Tubiana, N., Muloko, N., Tamalet, C., Chermann,
J.C., Kourilsky, F., and Sampol, J. (1991) Surface CD4 Density Remains
Constant on Lymphocytes of HIV-Infected Patients in the Progression of
Disease. Research in Immunology, 142, 291-298. http://dx.doi.org/10.1016/0923-2494(91)90078-W |
[13] |
Davis, K.A., Abrams, B., Iyer,
S.B., Hoffman, R.A. and Bishop, J.E. (1998) Determination of CD4 Antigen
Density on Cells: Role of Antibody Valency, Avidity, Clones, and
Conjugation. Cytometry, 33, 197-205. http://dx.doi.org/10.1002/(SICI)1097-0320(19981001)33:2<197::AID-CYTO14>3.0.CO;2-P |
[14] |
Wang L., Abbasi F., Ornatsky O.,
Cole K.D., Misakian M., Gaigalas A.K., He, H.-J., Marti, G.E., Tanner,
S. and Stebbings, R. (2012) Human CD4+ Lymphocytes for Antigen
Quantification: Characterization Using Conventional Flow Cytometry and
Mass Cytometry. Cytometry Part A, 81A, 567-575. http://dx.doi.org/10.1002/cyto.a.22060 |
[15] | Technical Bulletin of BD Biosciences: BD_FACSDiva_Stndrd_App_Setup_TechBulletin.pdf |
[16] |
Wang, L., Abbasi, F., Gaigalas,
A.K., Vogt, R.F. and Marti, G.E. (2006) Comparison of Fluorescein and
Phycoerythrin Conjugates for Quantifying CD20 Expression on Normal and
Leukemic B-Cells. Cytometry Part B: Clinical Cytometry, 70B, 410-415. http://dx.doi.org/10.1002/cyto.b.20140 eww141021lx |
评论
发表评论